Messenger Rna Encoding Cas9, Single Guide Rna Containing A Sequence Complementary To Human Alb Locus Gene, Intron 1, Target Region

2 trials 1 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

2 Sponsors

5 Countries

Phase I (FiH)

Phase I (FiH): 2

Oversight events:

1 corrective measure across 1 trial

View oversight register →

Sponsors using this IMP

Intellia Therapeutics Inc. 1 Regeneron Pharmaceuticals Inc. 1

All trials

2 total

A Trial to Learn if REGV131-LNP1265 is Safe and Works to Help the Body Make Clotting Factor in Adult Patients with Hemophilia B Recruiting

2023-507260-40-00 Phase I (FiH) 4 countries Regeneron Pharmaceuticals Inc.
A Phase 1/2 Study of NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease Ended

2023-508138-33-00 Phase I (FiH) 1 country Intellia Therapeutics Inc.

Showing 1–2 of 2 trials

← All drugs A–Z